bromocriptine has been researched along with cyclosporine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (48.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
| Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
| Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
| Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bernton, E; Bryant, H; Dave, J; Holaday, J | 1 |
| Nussenblatt, R | 1 |
| Lisch, W | 1 |
| Böhnke, M; Garweg, J; Mangold, I | 1 |
| Buskila, D; Shoenfeld, Y; Sukenik, S | 1 |
| Morikawa, S; Morkawa, K; Oseko, F | 1 |
| Shoenfeld, Y | 1 |
| Morikawa, K; Morikawa, S; Oseko, F | 1 |
| Clarke, WP; Heisenleder, DJ; Knight, RJ; Liu, H; Martinelli, GP | 1 |
| Neidhart, M | 1 |
| Barnas, U; Clodi, M; Hörl, WH; Kotzmann, H; Luger, A; Mayer, G; Mühlbacher, F; Mustafa, G; Riedl, M; Schmidt, A; Waldhäusl, W | 1 |
| Banli, O; Sözüer, E; Yilmaz, Z | 1 |
| Dehpour, AR; Jabarizadeh, N; Moezi, L; Samini, M; Shafaroodi, H; Tavakolifar, B | 1 |
| Brunner, LJ; Callahan, SM; Jin, R; Lu, SK | 1 |
| Chuang, E; Molitch, ME | 1 |
| Hong, SE; Kim, IK; Lee, SH; Park, JH; Park, SJ; Reed, JC | 1 |
4 review(s) available for bromocriptine and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The expanding use of immunosuppression in the treatment of non-infectious ocular disease.
Topics: Bromocriptine; Corneal Transplantation; Cyclosporine; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Humans; Immunosuppression Therapy; Keratoconjunctivitis; Prednisone; Uveitis | 1992 |
The possible role of prolactin in autoimmunity.
Topics: Animals; Antibody Formation; Arthritis, Experimental; Arthritis, Psoriatic; Autoantibodies; Autoimmune Diseases; Autoimmunity; Bromocriptine; Cyclosporine; Drug Synergism; Female; Humans; Hyperprolactinemia; Immunity, Cellular; Immunocompetence; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Pregnancy; Pregnancy Complications; Prolactin; Rats; Rheumatic Diseases; Uveitis | 1991 |
Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adjuvants, Immunologic; Androgens; Animals; Antibodies, Anti-Idiotypic; Antiphospholipid Syndrome; Aspirin; Bone Marrow Transplantation; Bromocriptine; Cyclosporine; Disease Models, Animal; Estrogens; Ethylenes; Heparin; Hydroxyquinolines; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; T-Lymphocytes, Regulatory | 1994 |
1 trial(s) available for bromocriptine and cyclosporine
| Article | Year |
|---|---|
The long-acting dopamine agonist bromocriptine mesylate as additive immunosuppressive drug after kidney transplantation.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Bromocriptine; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisolone; Prolactin; Prospective Studies | 1997 |
20 other study(ies) available for bromocriptine and cyclosporine
| Article | Year |
|---|---|
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A.
Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Corticosterone; Cyclosporine; Cysteamine; Glucocorticoids; Hemolytic Plaque Technique; Lymphocyte Activation; Male; Metoclopramide; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Perphenazine; Pituitary-Adrenal System; Prolactin; Spleen | 1992 |
[Comments on the contribution "Treatment of Goldmann-Favre syndrome with cyclosporin A and bromocriptine" by J. Garweg, M. Böhnke, J. Mangold].
Topics: Bromocriptine; Cyclosporine; Humans; Macular Edema; Retinal Degeneration; Syndrome | 1992 |
[Treatment of Goldmann-Favre syndrome with cyclosporin A and bromocriptine].
Topics: Adult; Bromocriptine; Cyclosporine; Diseases in Twins; Drug Therapy, Combination; Female; Fluorescein Angiography; Genes, Recessive; Humans; Prednisone; Retinitis Pigmentosa; Syndrome; Visual Acuity | 1991 |
Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro.
Topics: Antigens, CD; B-Lymphocytes; Bromocriptine; Cyclosporine; Humans; Immunoglobulins; Immunosuppressive Agents; Lymphocyte Activation; Tacrolimus | 1993 |
Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro.
Topics: Bromocriptine; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunosuppression Therapy; Lymphocyte Activation; Pokeweed Mitogens; Receptors, Interleukin-2; T-Lymphocytes | 1994 |
Prolactin suppression enhances the effects of perioperative donor-specific blood transfusions on graft survival.
Topics: Animals; Antibody Specificity; Bromocriptine; Cells, Cultured; Cyclosporine; Domperidone; Dopamine Agonists; Dopamine Antagonists; Graft Survival; Heart Transplantation; Host vs Graft Reaction; Immunosuppressive Agents; Intraoperative Period; Lymph Nodes; Lymphocyte Culture Test, Mixed; Lymphotoxin-alpha; Male; Prolactin; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Spleen; Transfusion Reaction; Transplantation, Homologous | 1996 |
Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats.
Topics: Animals; Arthritis, Experimental; Autoimmune Diseases; Bromocriptine; Cyclosporine; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Drug Synergism; Female; Male; Ornithine Decarboxylase; Polyarteritis Nodosa; Rats; Rats, Inbred BB; Rats, Inbred Lew; Rats, Sprague-Dawley; Thymus Gland; Uveitis | 1996 |
Effect of combination of cyclosporine A and bromocriptine on survival of renal allografts in dogs.
Topics: Animals; Blood Urea Nitrogen; Bromocriptine; Creatinine; Cyclosporine; Dogs; Drug Therapy, Combination; Graft Rejection; Graft Survival; Kidney Transplantation; Time Factors; Transplantation, Homologous | 1998 |
Evidences for involvement of nitric oxide in the gastroprotective effect of bromocriptine and cyclosporin A on water immersion stress-induced gastric lesions.
Topics: Animals; Bromocriptine; Cyclosporine; Cytoprotection; Gastric Mucosa; Nitric Oxide; Rats; Stomach Ulcer; Stress, Physiological | 2002 |
Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactin.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Bromocriptine; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P450 Family 2; Enzyme Inhibitors; Male; Membrane Proteins; Microsomes, Liver; Prolactin; Rats; Rats, Sprague-Dawley; Steroid 16-alpha-Hydroxylase | 2004 |
Prolactin and autoimmune diseases in humans.
Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin | 2007 |
Cyclosporine A and bromocriptine attenuate cell death mediated by intracellular calcium mobilization.
Topics: Apoptosis; Bromocriptine; Calcium; Cell Line, Tumor; Cyclosporine; Endoplasmic Reticulum Chaperone BiP; HCT116 Cells; Heat-Shock Proteins; HeLa Cells; High-Throughput Screening Assays; Humans; Immunosuppressive Agents; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Thapsigargin; Tunicamycin; Unfolded Protein Response | 2012 |